title: Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo.
abstract: BACKGROUND
  The murine homologue of human vasohibin (mVASH1), a putative antiangiogenic protein, was investigated for its effects on in vitro and in vivo angiogenesis.
  
  
  METHODS
  Cell growth and migration were analyzed in murine fibroblasts, smooth muscle cells and endothelial cells. Angiogenic sprouting was studied in human umbilical vein endothelial cells (HUVECs) in the spheroid sprouting assay. In vivo effects on blood vessel formation were investigated in the chorioallantoic membrane (CAM) assay and in the C57BL/6 melanoma xenograft model.
  
  
  RESULTS
  Purified murine and human VASH1 protein induced apoptosis of murine fibroblasts in vitro, but not of vascular aortic smooth muscle cells (AoSMC) or endothelial cells. Adenoviral overexpression of murine and human VASH1 inhibited capillary sprouting of HUVECs in the spheroid assay. Administration of recombinant murine and human VASH1 inhibited growth of large vessels in the CAM assay and promoted the formation of a dense, fine vascular network. Murine VASH1-overexpressing B16F10 melanomas displayed a reduction in large vessels and vascular area. Moreover, tumors showed more microvessels that stained positive for the mural cell markers alpha-smooth muscle cell actin (ASMA) and proteoglycan (NG2).
  
  
  CONCLUSIONS
  Our data imply that murine VASH1 causes angiogenic remodelling by inhibiting angiogenic sprouting and large vessel growth, thereby supporting the formation of a vascular bed consisting predominantly of mature microvessels.
authors.affiliation: Division of Internal Medicine V, Tumor Biology & Angiogenesis Laboratory, Medical University Innsbruck, Innrain 66, A-6020 Innsbruck, Austria. johann.kern@i-med.ac.at
authors.forename: Johann
authors.initials: J
authors.lastname: Kern
authors.forename: Michael
authors.initials: M
authors.lastname: Steurer
authors.forename: Günther
authors.initials: G
authors.lastname: Gastl
authors.forename: Eberhard
authors.initials: E
authors.lastname: Gunsilius
authors.forename: Gerold
authors.initials: G
authors.lastname: Untergasser
mesh_terms: D020533:Angiogenesis Inhibitors / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001808:Blood Vessels / Q000254:growth & development* / Q000378:metabolism; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D002642:Chick Embryo; D049033:Chorioallantoic Membrane / Q000098:blood supply* / Q000378:metabolism; D015536:Down-Regulation; D004730:Endothelium, Vascular / Q000254:growth & development / Q000378:metabolism; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D009389:Neovascularization, Pathologic; D018919:Neovascularization, Physiologic; D018874:Spheroids, Cellular; D023041:Xenograft Model Antitumor Assays
chemical_list: D020533:Angiogenesis Inhibitors; D018797:Cell Cycle Proteins; C493181:VASH1 protein, human
references.citation: J Cell Mol Med. 2000 Oct-Dec;4(4):262-269
references.pmid: 12067460
references.citation: J Clin Pathol. 2004 May;57(5):504-12
references.pmid: 15113858
references.citation: Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):478-84
references.pmid: 18187668
references.citation: FASEB J. 2004 Feb;18(2):326-8
references.pmid: 14688196
references.citation: Int J Cancer. 2008 Apr 1;122(7):1539-47
references.pmid: 18033687
references.citation: J Clin Invest. 1973 Nov;52(11):2745-56
references.pmid: 4355998
references.citation: J Cell Mol Med. 2005 Oct-Dec;9(4):777-94
references.pmid: 16364190
references.citation: J Cell Sci. 1999 Oct;112 ( Pt 19):3249-58
references.pmid: 10504330
references.citation: J Clin Invest. 2004 Oct;114(7):884-6
references.pmid: 15467823
references.citation: Cancer Res. 2000 Dec 15;60(24):7075-83
references.pmid: 11156414
references.citation: Biochem Biophys Res Commun. 2005 Feb 18;327(3):700-6
references.pmid: 15649403
references.citation: J Clin Invest. 2004 Oct;114(7):898-907
references.pmid: 15467828
references.citation: Science. 1987 Jan 23;235(4787):442-7
references.pmid: 2432664
references.citation: Dev Dyn. 2007 May;236(5):1358-62
references.pmid: 17394205
references.citation: J Cell Mol Med. 2006 Jul-Sep;10(3):588-612
references.pmid: 16989723
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: Am J Pathol. 2009 Jul;175(1):430-9
references.pmid: 19498005
references.citation: J Cell Mol Med. 2007 Mar-Apr;11(2):176-205
references.pmid: 17488472
references.citation: FASEB J. 2006 Apr;20(6):723-5
references.pmid: 16473886
references.citation: Blood. 2009 May 7;113(19):4810-8
references.pmid: 19204325
references.citation: Angiogenesis. 2001;4(4):289-98
references.pmid: 12197474